Loading...
XETR
M3V
Market cap54mUSD
Apr 29, Last price  
26.60EUR
1D
0.76%
1Q
3.94%
Jan 2017
-30.43%
IPO
-47.20%
Name

Mevis Medical Solutions AG

Chart & Performance

D1W1MN
P/E
10.61
P/S
2.85
EPS
2.51
Div Yield, %
3.60%
Shrs. gr., 5y
Rev. gr., 5y
-1.25%
Revenues
17m
-2.13%
8,342,0007,892,00010,844,00013,869,00014,291,00013,678,00013,347,00014,617,00013,091,00016,014,00016,121,29318,540,00016,758,00018,073,00017,131,00016,214,00018,762,00017,341,94916,972,000
Net income
5m
-7.29%
2,935,000132,0002,114,000398,000-8,349,000-4,092,0002,164,0003,681,0003,713,0006,735,0004,566,6555,622,0007,171,0008,070,9395,703,9074,545,6817,789,0474,919,5464,560,821
CFO
3m
-46.25%
4,595,000-2,468,0002,908,0003,071,0004,950,0005,107,0005,288,0007,483,0004,831,0006,581,0003,509,0007,324,0005,521,0006,544,7322,889,8589,131,2044,857,4765,854,1293,146,366
Dividend
Mar 20, 20240.95 EUR/sh
Earnings
May 26, 2025

Profile

MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.
IPO date
Nov 16, 2007
Employees
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑092023‑092022‑092021‑092020‑092019‑092018‑092017‑092016‑092015‑12
Income
Revenues
16,972
-2.13%
17,342
-7.57%
18,762
15.71%
Cost of revenue
979
10,781
1,191
Unusual Expense (Income)
NOPBT
15,993
6,561
17,571
NOPBT Margin
94.23%
37.83%
93.65%
Operating Taxes
126
114
87
Tax Rate
0.79%
1.74%
0.50%
NOPAT
15,867
6,447
17,484
Net income
4,561
-7.29%
4,920
-36.84%
7,789
71.35%
Dividends
(4,546)
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
(1,517)
Long-term debt
Deferred revenue
Other long-term liabilities
2,301
3,379
3,534
Net debt
(6,528)
(8,056)
(27,375)
Cash flow
Cash from operating activities
3,146
5,854
4,857
CAPEX
(80)
Cash from investing activities
907
990
59
Cash from financing activities
(7,789)
FCF
15,698
6,463
17,444
Balance
Cash
6,528
7,744
9,320
Long term investments
312
16,537
Excess cash
5,680
7,189
24,920
Stockholders' equity
6,360
6,365
6,365
Invested Capital
14,447
14,841
13,350
ROIC
108.35%
45.74%
135.85%
ROCE
79.46%
30.94%
88.37%
EV
Common stock shares outstanding
1,820
1,820
1,820
Price
Market cap
EV
EBITDA
16,126
6,657
17,664
EV/EBITDA
Interest
20
43
4
Interest/NOPBT
0.12%
0.65%
0.02%